“mediphase-venture-partners” Archives

Entry Author Date Location
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
Relypsa Gets Another $50M for Drug to Fight Excess Potassium 08/13/12 San Francisco
MedNetworks, Co-Founded by Harvard’s Nicholas Christakis, Aims to Tap Healthcare’s Hidden Social Networks 10/27/10 Boston
Relypsa Snags $70M Venture Round to Get Rid of Excess Potassium in Blood 09/13/10 San Francisco
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News 06/02/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing 06/01/10 Boston
Relypsa Lands $10,000,000 Series A Financing Round 03/11/09 San Francisco
Top 10 Q3 Venture Deals in the Northwest 10/20/08 Seattle
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News 10/16/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV 10/14/08 Boston
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes 09/25/08 Boston
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News 08/13/08 Boston
A123 Files For “Lucky” IPO, BP Shells out $90M for Verenium’s Biofuel Tech, Alnylam Ventures into New RNA Realm, & More Deals News 08/11/08 Boston
Wellpartner, Inc. Garners $16,100,000 Series D Financing 08/01/08 Seattle
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News 05/07/08 Boston
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News 05/05/08 Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals 05/01/08 Boston
TetraPhase Aims to Fill the Antibiotic Pipeline—and its Executive Office 10/05/07 Boston
TetraPhase Pharmaceuticals, Inc. Garners $25,000,000 Series A Funding Round 11/27/06 Boston
Page 1 of 1